Cardiovascular Disease, Aging, and Clonal Hematopoiesis

Annual Review of Pathology: Mechanisms of Disease - Tập 15 Số 1 - Trang 419-438 - 2020
Megan A. Evans1, Soichi Sano1, Kenneth Walsh1
1Hematovascular Biology Center and the Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA;, ,

Tóm tắt

Traditional risk factors are incompletely predictive of cardiovascular disease development, a leading cause of death in the elderly. Recent epidemiological studies have shown that human aging is associated with an increased frequency of somatic mutations in the hematopoietic system, which provide a competitive advantage to a mutant cell, thus allowing for its clonal expansion, a phenomenon known as clonal hematopoiesis. Unexpectedly, these mutations have been associated with a higher incidence of cardiovascular disease, suggesting a previously unrecognized connection between somatic mutations in hematopoietic cells and cardiovascular disease. Here, we provide an up-to-date review of clonal hematopoiesis and its association with aging and cardiovascular disease. We also give a detailed report of the experimental studies that have been instrumental in understanding the relationship between clonal hematopoiesis and cardiovascular disease and have shed light on the mechanisms by which hematopoietic somatic mutations contribute to disease pathology.

Từ khóa


Tài liệu tham khảo

WHO (World Health Organ.), 2017, WHO

Bloom D, 2011, The Global Economic Burden of Non-Communicable Diseases

10.1016/S0140-6736(08)60313-X

10.1007/s12551-017-0255-9

10.1016/S0140-6736(12)61766-8

10.1038/nrg.2016.160

10.1016/S1474-4422(06)70683-4

10.1056/NEJMra1105239

10.1098/rstb.2009.0317

10.1126/science.aab4082

10.1038/nrg.2016.145

10.1186/1476-069X-10-S1-S12

10.1056/NEJMoa1408617

10.1056/NEJMoa1701719

10.1056/NEJMoa1409405

10.1056/NEJMoa052800

10.1038/ng.2700

10.1016/j.gde.2014.04.002

10.1016/j.cell.2012.06.023

10.1016/j.stem.2018.01.011

10.1182/blood.V88.1.59.59

10.1038/ng.2413

10.1038/ng.2270

10.1038/ng.2271

10.1038/nm.3733

10.1093/carcin/bgq087

10.1182/blood-2015-03-631747

10.1016/bs.acr.2018.12.003

10.1182/blood-2017-07-746453

10.1038/s41586-018-0321-x

10.1182/blood-2017-02-769869

10.1016/j.celrep.2015.02.005

10.1038/ncomms12484

10.18632/aging.100351

10.3390/ijms19092567

10.1038/s41591-018-0081-z

10.1038/s41586-018-0317-6

10.1001/jamacardio.2018.3965

10.1093/eurheartj/ehz591

10.1200/JCO.2016.71.6712

10.1016/S1470-2045(16)30626-X

10.1253/circj.CJ-18-0871

10.1016/j.stem.2017.07.010

10.1182/blood-2018-05-850339

10.1001/jamaoncol.2015.6053

10.1038/bjc.2015.79

10.1038/s41525-017-0025-4

10.1016/j.exphem.2017.11.002

10.1038/s41586-018-0125-z

10.1182/blood-2011-11-394775

10.1126/science.aag1381

10.1161/CIRCRESAHA.118.313225

10.1016/j.jacc.2017.12.037

10.1016/j.jacbts.2019.05.013

10.1126/science.1210597

10.1161/CIRCRESAHA.117.312115

10.1038/nature15252

10.1182/blood-2017-04-777029

10.1182/blood-2009-02-205690

10.1038/leu.2009.47

10.1038/ng.391

10.1016/j.ccr.2011.06.001

10.1016/j.ccr.2011.06.003

10.1182/blood-2010-12-325241

10.1016/j.tibs.2016.09.002

10.1056/NEJMoa1707914

10.1016/S0140-6736(17)32814-3

Svennson E, 2018, Circulation, 138, 15111

10.1038/nrg.2017.80

10.1038/ng.1009

10.1084/jem.20060750

10.1038/leu.2015.358

10.1038/ng.3610

10.1172/JCI93041

10.1073/pnas.1616420114

10.4049/jimmunol.0802960

10.4049/jimmunol.1203229

10.1073/pnas.1103803109

10.1038/ni.3464

10.1182/blood-2015-06-652941

10.1016/j.cyto.2018.03.041

10.1016/S0140-6736(05)71142-9

10.1182/asheducation-2016.1.552

10.1016/j.ccr.2005.03.023

10.1182/blood-2016-10-696005

10.1038/nature03546

10.1111/j.1365-2141.2005.05682.x

10.1111/j.1365-2141.2007.06497.x

10.1182/blood-2006-04-017392

10.18632/oncotarget.19211

10.1182/blood.2019001113

10.1161/CIRCRESAHA.118.313283

10.1126/scitranslmed.aan8292

10.1155/2019/1209307

10.1182/blood-2013-07-514992

10.1084/jem.20160530